Carbenoxolone induces apoptosis and inhibits survivin and survivin-ΔEx3 genes expression in human leukemia K562 cells

DARU, Journal of Pharmaceutical Sciences

Volumn 19, Issue 6, 2011, Pages 455-461

  Moosavi, M A ^a   Moasses Ghafary, S ^a   Asvadi Kermani, I ^b   Hamzeiy, H ^c   Rahmati, M ^d   Ahmadi, A H ^b   Nikanfar, A ^b   Sanaat, Z ^b   Asadi Khiavi, M ^a,b,c,e  

^a UNIVERSITY OF TABRIZ   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Faculty of Pharmacy   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Carbenoxolone; LeukemiaSurvivin

Indexed keywords

CARBENOXOLONE; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION ASSAY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG STRUCTURE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; K-562 CELL LINE; LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SURVIVIN GENE; UPREGULATION;

EID: 84919395064     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.111/J.1560-8115     Document Type: Article

References (26)

1. Kalidas M, Kantarjian H, Talpaz M. Chronic Myelogenous Leukemia. JAMA. 2001; 286: 895-8.
2. Valent P. Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches. Biologics: Targets & Therapy. 2007; 1: 433-48.
3. Fukuda S, Pelus LM. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood. 2001; 98: 2091-2100.
4. Sah NK, Khan Z, Khan GJ, Bisen PS. Structural, functional and therapeutic biology of survivin. Cancer Lett. 2006; 244: 164-71.
5. Doolittle H, Morel A, Talbot D. Survivin-directed Anticancer Therapies-A Review of Pre-clinical Data and Early-phase Clinical Trials. Eur Oncology. 2010;6: 10-4.
6. DuffyMJ, O'Donovan N, Brennan DJ, GallagherWM, Ryan BM. Survivin: A promising tumor biomarker. 2007; 249: 49-60.
7. Contea E, Stagnob F, Guglielmob P, Scutoa A, Consoli C, M Angelo. Survivin expression in chronic myeloid leukemia. Cancer Lett. 2005; 225:105-10.
8. Hausmann W, Tarnoky AL. Biochemical effects of short-term treatment with Carbenoxolone disodium. Brit J Pharmacol. 1966; 26: 412-20.
9. Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol. 2006; 46: 167-92.
10. Salvi M, Fiore C, Battaglia V, Palermo M, Armanini D, Toninello A. Carbenoxolone induces oxidative stress in Liver mitochondria, which is responsible for transition pore opening. Endocrinol. 2005; 146: 2306-12.
11. Hundertmark S, hler HBü, Rudolf M, Weitzel HK, Ragosch V. Inhibition of 11β-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells. J Endocrinol. 1997; 155: 171-80.
12. Trovato-Salinaro A, Trovato-Salinaro E, Marco Failla M, Mastruzzo C, Tomaselli V. and et al. Altered intercellular communication in lung fibroblast cultures from patients with idiopathic pulmonary fibrosis. Respir Res. 2006; 7: 1-9.
13. Moosavi MA, Moasses Ghafary S, Asadi M, Asvadi-Kermani I. Growth inhibitory and apoptotic effects of carbenoxolone in human leukemia K562 cell Line. SJKU 2011, 16: 27-37.
14. Lozzio BB, Lozzio CB. Properties of the K562 cell line derived from a patient with choronic myeloid leukemia. Int J Cancer. 1977; 19: 136-9.
15. Law JC, Ritke MK, Yalowich JC, Leder GH, Ferrell RE. Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line. Leuk Res 1993; 17: 1045-50.
16. Moosavi MA, Yazdanparast R, Lotfi A. GTP induces S-phase call-cycle arrest and inhibits DNA synthesis in K562 cells but not in normal human peripheral lymphocytes. J Bio chem Mol Biol. 2006; 39: 492-501.
17. Schimmer AD. Apoptosis in leukemia: From molecular pathways to targeted therapies. Best Pract Res Clin Haematol. 2008; 21: 5-11.
18. Kawashima D, Asai M, Katagiri K, Takeuchi R, Ohtsuka K. Reinvestigation of the effect of carbenoxolone on the induction of heat shock proteins. Cell Stress and Chaperones. 2009; 14: 535-43.
19. Mirkina II, Mernenko OA, Satpaev DK, Karelin AA, Blishchenko EY. Cytolytic processes induced by TNF in L929 and K562 differ in DNA fragmentation mechanisms. Immunol Lett. 1996; 52: 105-8.
20. Pivato LS, Constantin RP, Ishii-Iwamoto EL, Yamamoto NS, Constantin J, Bracht A. Metabolic effects of carbenoxolone in the rat liver. J Biochem Mol Toxicol. 2006; 20:230-40.
21. Waddell BJ, Susan Hisheh S, Dharmarajan AM, Burton PJ. Apoptosis in rat placenta is zone-dependent and stimulated by glucocorticoids. BOR. 2000; 63: 1913-17.
22. Edemir B, Reuter S, Borgulya R, Schröter R, Neugebauer U, Gabriëls G, Eberhard Schlatter E. Acute rejection modulates gene expression in the collecting duct. J Am Soc Nephrol. 2008; 19: 538-46.
23. Wu YH, You Y, Chen ZC, Zou P. Reversal of drug resistance by silencing Survivin gene expression in acute myeloid leukemia cells. Acta Biocemica polonica. 2008; 55:673-80.
24. Pivato LS, Constantin RP, Ishii-Iwamoto EL, Yamamoto NS, Constantin J, Bracht A. Metabolic effects of carbenoxolone in the rat liver. J Biochem Mol Toxicol. 2006; 20:230-40.
25. Greenstein S, Ghias K, Krett NL. and Rosen ST. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res. 2002; 8, 1681-94.
26. Winmill RE, Hedrick MS. Gap junction blockade with Carbenoxolone differentially affects fictive breathing in larval and adult bullfrogs. Respir Physiol Neurobiol. 2003; 138: 239-51.